Guertin, J. R., Mitchell, D., Ali, F., & LeLorier, J. (2015). Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug. Clinicoecon Outcomes Res.
Citación estilo ChicagoGuertin, Jason R., Dominic Mitchell, Farzad Ali, y Jacques LeLorier. "Bias Within Economic Evaluations – the Impact of Considering the Future Entry of Lower-cost Generics On Currently Estimated Incremental Cost-effectiveness Ratios of a New Drug." Clinicoecon Outcomes Res 2015.
Cita MLAGuertin, Jason R., Dominic Mitchell, Farzad Ali, y Jacques LeLorier. "Bias Within Economic Evaluations – the Impact of Considering the Future Entry of Lower-cost Generics On Currently Estimated Incremental Cost-effectiveness Ratios of a New Drug." Clinicoecon Outcomes Res 2015.